Key Takeaway: Vor Bio, a clinical-stage cell and genome engineering company, is set to participate in the 2023 Wedbush PacGrow Healthcare Conference. The event will feature in-person 1x1 investor meetings occurring on August 8-9, 2023, at the Lotte Palace Hotel in New York, NY. Vor Bio is focused on engineering hematopoietic stem cells with the goal of improving therapies for patients with blood cancers, highlighting their innovative approach to treatment.
Price reaction · baseline $60.4 (2023-07-31 close) · hit after-hours · clean, no other VOR news in the window
day 0 close · peak
+5%
Market Sentiment Analysis
POSITIVE FACTORS
Vor Bio is actively engaging with investors at a reputable conference.
The company's focus on changing treatment standards in blood cancers showcases innovation and potential impact.
Involvement in the conference suggests growing interest and validation of their work.
BiopharmaWatch Analysis
From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+442%
120-day peak, hindsight
Typical move
18.8%
average across 6 past catalysts
Cash runway
~55 mo
Minimal dilution risk
Lead asset
Telitacicept
Phase 3 · Primary Sjogren's Disease
Full Press Release Details
CAMBRIDGE, Mass., Aug. 01, 2023 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage cell and genome engineering company, will host in-person 1x1 investor meetings at the 2023 Wedbush PacGrow Healthcare Conference.
Wedbush PacGrow Healthcare Conference
1x1 Investor Meetings: August 8-9, 2023
Location: Lotte Palace Hotel, New York, NY
Vor Bio is a clinical-stage cell and genome engineering company that aims to change the standard of care for patients with blood cancers by engineering hematopoietic stem cells to enable targeted therapies post-transplant. For more information, visit: www.vorbio.com.
Frequently Asked Questions
When is the 2023 Wedbush PacGrow Healthcare Conference?
The conference will take place on August 8-9, 2023.
Where will the investor meetings be held?
Investor meetings will be at the Lotte Palace Hotel in New York, NY.
What is Vor Bio's focus in healthcare?
Vor Bio focuses on engineering hematopoietic stem cells for blood cancer care.
What type of company is Vor Bio?
Vor Bio is a clinical-stage cell and genome engineering company.